OPPM
PGNX

Opus Point Partners Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Opus Point Partners Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$88K Hold
2018
Q1 		$81K Sell
2017
Q4 		$130K Hold
2017
Q3 		$160K Hold
2017
Q2 		$148K Sell
2017
Q1 		$411K Buy